About Intima Bioscience
Intima Bioscience is a company based in New York (United States) founded in 2014. Intima Bioscience offers products and services including Checkpoint Cell Therapy and Tumor Infiltrating Lymphocytes (TIL). Intima Bioscience operates in a competitive market with competitors including eGenesis, Beam Therapeutics, Korro Bio, Scribe Therapeutics and Tessera Therapeutics, among others.
- Headquarter New York, United States
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
- Legal Name Intima Bioscience, Inc
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
-
Investors
Not available
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Intima Bioscience
Intima Bioscience offers a comprehensive portfolio of products and services, including Checkpoint Cell Therapy and Tumor Infiltrating Lymphocytes (TIL).
Uses CRISPR to edit T cells for inhibiting immune checkpoints in cancers
Genetically engineered lymphocytes for treating solid tumor cancers
Funding Insights of Intima Bioscience
Detailed funding history for Intima Bioscience
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Intima Bioscience
Investment portfolio details for Intima Bioscience
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Intima Bioscience
Detailed financials for Intima Bioscience
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Intima Bioscience Comparisons
Peer comparison for Intima Bioscience
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Intima Bioscience
Intima Bioscience operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as eGenesis, Beam Therapeutics, Korro Bio, Scribe Therapeutics and Tessera Therapeutics, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Gene transplantation platform for humanizing pig cells is developed.
|
|
| Locked | Locked | Locked |
Developer of gene therapy using CRISPR base editing to treat diseases
|
|
| Locked | Locked | Locked |
RNA-editing technologies are provided for precision medicine applications.
|
|
| Locked | Locked | Locked |
A CRISPR-based gene-editing platform is developed for therapeutic applications.
|
|
| Locked | Locked | Locked |
New genome engineering technology is provided for treating multiple diseases.
|
|
| Locked | Locked | Locked |
Developer of therapeutics for infectious disease and inflammatory indications
|
Detailed competitors of Intima Bioscience
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Intima Bioscience
Complete news archive for Intima Bioscience
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Intima Bioscience
Intima Bioscience was founded in 2014.
Intima Bioscience is headquartered in New York, United States. It is registered at New York, New York, United States.
Intima Bioscience was founded in 2014 in New York, United States, within the biotechnology sector. A gene and cell therapeutic platform is being developed for gastrointestinal cancer treatment. Clinical trials are underway, with experiments conducted via the Molecular and Cell Therapy (MCT) GMP manufacturing platform. CRISPR technology is employed to engineer neoantigen-specific tumor-infiltrating lymphocytes that inhibit the intracellular immune checkpoint CISH.
Intima Bioscience's top competitors include eGenesis, Tessera Therapeutics and Korro Bio.
Intima Bioscience offers Checkpoint Cell Therapy and Tumor Infiltrating Lymphocytes (TIL).